A comprehensive view of Mitsubishi Tanabe Pharma Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GSK and Medicago, an affiliate of Mitsubishi Tanabe Pharma, announce Health Canada approval of the COVIFENZ COVID-19 vaccine for individuals age 18 to 64
Published: February 24, 2022 by GlaxoSmithKline PLC
Mitsubishi Tanabe Pharma announces start of Phase 1/2 clinical study in Japan of the plant-derived virus-like particle vaccine candidate combined with GSK's adjuvant for prevention of COVID-19
Published: September 30, 2021 by Mitsubishi Tanabe Pharma Corp.
Mitsubishi Tanabe Pharma America launches Exservan in oral film formulation for the treatment of amyotrophic lateral sclerosis in the US; drug meets needs of patients who have difficulty swallowing, company says
Published: July 01, 2021 by Mitsubishi Tanabe Pharma Corp.

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count